Trials / Conditions / Hereditary Angioedema Types I and II

Hereditary Angioedema Types I and II

10 registered clinical trials studyying Hereditary Angioedema Types I and II — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Study of Oral Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adolescents and Adul NCT06343779	Pharvaris Netherlands B.V.	Phase 3
Enrolling By Invitation	Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angio NCT05396105	Pharvaris Netherlands B.V.	Phase 2 / Phase 3
Completed	Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary A NCT05047185	Pharvaris Netherlands B.V.	Phase 2
Completed	Dose-ranging Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary An NCT04618211	Pharvaris Netherlands B.V.	Phase 2
Completed	A Study to Evaluate the Long-term Clinical Safety and Efficacy of Subcutaneously Administered C1-esterase Inhi NCT02316353	CSL Behring	Phase 3
Completed	A Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1-esterase Inhibitor in t NCT01912456	CSL Behring	Phase 3
Withdrawn	Study to Assess the Tolerability and Safety of Ecallantide in Children and Adolescents With Hereditary Angioed NCT01832896	NYU Langone Health	Phase 2
Completed	A Study to Evaluate the Safety and Pharmacokinetics of Two Formulations of C1-esterase Inhibitor NCT01760343	CSL Behring	Phase 1
Completed	A Study to Evaluate the Clinical Pharmacology and Safety of C1-esterase Inhibitor Administered by the Subcutan NCT01576523	CSL Behring	Phase 1 / Phase 2
Completed	Postmarketing Immunogenicity Study in HAE Subjects Treated With Berinert NCT01467947	CSL Behring	Phase 4